ClinicalTrials.gg
RecruitingNCT06825611Updated Oct 26, 2026

Detecting and Monitoring Scoliosis Without Radiography: Standard Radiographic Monitoring Program Versus Self-Screening With Momentum SpineTM

An interventional study of Momentum Application in Adolescent Idiopathic Scoliosis, sponsored by Children's Hospital Los Angeles. Recruiting at 1 site in United States. Open to participants aged 8 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Children's Hospital Los Angeles · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Apr 2025; still recruiting 1 year 7 months later.
Updated Oct 26, 2026Now RecruitingFirst site in United States+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
8 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 153 studies in Scoliosis with a site in United States — 42 open to participants now, 51 under way, 2 of them phase 3. Scoliosis · United States.

Planned enrollment
18th of 91
100 · median 58
Started
2025
with 8 others
No phase
65 of 153
16 open now
Primary completion
2027-08
later than 28 of 50 live
Registered
143rd of 153
by date
Lead sponsor
3 of 153
Children's Hospital Los Angeles

Among the 153 studies in Scoliosis with a site in United States, this one is the 18th largest by planned enrollment of the 91 interventional ones that give a count, is one of 9 that started in 2025, is one of 65 with no phase, reaches primary completion later than 28 of the 50 other live ones, and was the 143rd registered.

Scoliosis

660 studies on the registry are indexed under Scoliosis; 185 are open to participants now.

Browse Scoliosis studies →

Open to participants now

42 of the 153 studies in Scoliosis with a site in United States are open now. Recruiting first, the newest first:

36 more — sign in →

All 42 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.

This study: 8 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 153 studies in Scoliosis with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is for the Momentum SpineTM application to accurately detect scoliosis progression, including accuracy, margin of error, sensitivity, specificity, AUC, and overall agreement with radiographs in 8-18 year olds with adolescent idiopathic scoliosis. The main question it aims to answer [is/are]:

  • Based on previous data it is hypothesize that Momentum SpineTM imaging software will be able to accurately detect scoliosis progression (>= 7 degrees), including accuracy, margin of error, sensitivity, specificity, AUC, and overall agreement with radiographs.
  • Based on the above hypothesis that Momentum SpineTM is able to accurately detect scoliosis and curve progression (>= 7 degrees).
  • It is hypothesized there will be indications for accelerated clinical visits based on at home detection of progression, and that these visits will be accurate and necessary.
  • It is hypothesized that there will be a proportion of standard care visits that are deemed unnecessary, and that the application is able to accurately predict these visits.

Participants will:

  • Use Momentum SpineTM assessment from home to perform body scans at 1-month intervals on personal device and during the clinical visit.
  • Received monthly scans that will be evaluated by the provider using the application.
  • Receive additional scans as warranted.
  • Complete net promoter score (NPS) within the application following completion of a body scan.
  • Complete a patient satisfaction survey following 6 months of application usage.
03

Conditions studied

  • Adolescent Idiopathic Scoliosis

Browse trials for

Keywords

  • spinal curve monitoring
  • Scoliosis mobile application
04

Who can participate

Ages eligible
8 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children between the ages of 8-18 years of age
  • Confirmed radiographic diagnosis of adolescent idiopathic scoliosis
  • No history of spinal/ chest surgery.
  • Participants who have had spine x-rays ±1 week as baseline visit at CHLA will be included in the study.
  • Participants who have identifiable markings such as tattoos or birthmarks can be included in the study, though their markings will be covered with tape.

Exclusion criteria

Exclusion Criteria:

  • Participants who have had x-rays in a brace will not be included.
  • Participants who have had an x-ray from another institution will not be included in the study. X-rays from out of community are typically done with a different and lower quality machine then the one at our institution. Additionally, we do not have consent from outside institutions to use their x-rays for research purposes.
  • Participants with a confirmed pregnancy will not be included. Pregnancy status will be self-reported by participants.
  • Participants with the existence of a second deformity which may affect topographic assessment will be excluded (e.g. Limb length discrepancy greater than 2cm).
  • Families who do not speak English and Spanish will be unable to participate as the application is only available in English and Spanish at this time.
  • Families who do not have access to their own compatible personal smart phone device will be unable to participate in the study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Momentum Application

    Patients diagnosed with scoliosis between 8-18 years of age

    Device: Momentum Application

Interventions

  • DeviceMomentum Application

    A mobile application to scan and predict spinal curvature. The application monitors curvature and track changes over time.

06

What researchers measure

Primary outcomes

  1. Accuracy of Scoliosis Progression

    Progression will be defined as a change of greater than or equal to 7 degrees. The progression between the application will be compared to the radiographs done manually, with evaluation of the margin of error, sensitivity, specificity, AUC, and overall agreement with the radiographs.

    Time frame: Immediately from enrollment and monthly through study completion

Secondary outcomes

  1. Proportion of follow-up visits that were correctly accelerated

    Accelerated visits are defined as medical appointments less than 6 months apart (sooner than routine follow-up) suggested by the Momentum Spine mobile application. When Momentum Spine detects progression on 3D models obtained at home, it suggests the clinical team see that patient sooner than the planned semi-annual visit in order to implement treatments earlier (bracing, change in brace, etc.). This endpoint will calculate the percentage of accelerated visits suggested by Momentum Spine where scoliosis progression was present as well as where a change in treatment was required.

    Time frame: Immediately from enrollment through study completion, at an average of 2 years

  2. Necessity of visit

    Coronal curve magnitude between site-specific X-ray measurements and coronal curve magnitude predictions output by Momentum Spine will be compared . The cutoff to determine whether the predicted coronal curve magnitude will be a difference of +/- 7 degrees when compared to the average of the readings from x-rays. Progression noted via Momentum Spine and on radiographs will be compared. Necessary visit = Radiographic Progression \>7 degrees Unnecessary visit = Radiographic Progression \<7 degrees Percentage agreement between Radiographic and MS progression values, with a cutoff point of 7 degrees, will be assessed.

    Time frame: Immediately from enrollment and monthly through study completion

  3. Proportion of avoidable x-rays using Momentum Spine

    An avoidable x-ray is defined as the percentage of radiographs obtained as part of routine semi-annual follow-up that show an absence of scoliosis progression where Momentum Spine was in agreement. This metric demonstrates that Momentum Spine is an accurate tool for determining when spinal radiographs are necessary.

    Time frame: Immediately from enrollment and monthly through study completion

  4. Patient Satisfaction Survey

    The patient satisfaction survey consists of 6 open-ended questions to understand what the experience has been for the individual using the application.

    Time frame: Only at the 6 month visit

  5. Net Promoter Score

    The Net Promoter Score (NPS) is measured by collecting patient/parent ratings on a 0-10 scale in response to questions on how likely they would use the app. The data is collected via a survey embedded within the product. The score uses a scale between a minimum value of 0 (worst) to a maximum value of 5(best).

    Time frame: Immediately from enrollment and monthly through study completion

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2025 (actual). Primary completion is estimated for Aug 2027, 27 months after the start.

Of 224 non-industry interventional studies with no phase under Scoliosis, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 58. This study's planned 27 months is above that.

Counting every sponsor, half of 234 studies reached it within 22 months; a quarter within 8 and three quarters within 60.

Start moved once since we started tracking on Sep 25, 2026: Mar 2025 → Apr 2025, on Oct 26, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2025
First posted
Feb 13, 2025
StartActual
Apr 20, 2025was Mar 2025
Primary completionEst.
Aug 15, 2027
CompletionEst.
Aug 15, 2027
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 26, 2026
Sites
1 site added — first site in United States
Show site
  • Children's Hospital Los Angeles · Los Angeles, United States
Oct 26, 2026
Start date
Mar 15, 2025→Apr 20, 2025 (actual)
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in United States
    Show site
    • Children's Hospital Los Angeles · Los Angeles, United States
    Start date Mar 15, 2025→Apr 20, 2025 (now actual)
    + 4 other changes: index terms, identifiers, verification date and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06825611
Collaborators
Momentum Health Inc.
Responsible party
Lindsay Andras (Attending Physician, Children's Hospital Los Angeles) — Principal investigator
First posted
Feb 13, 2025
Start date
Apr 20, 2025
Primary completion
Aug 15, 2027 (estimated)
Completion
Aug 15, 2027 (estimated)
Last update
Oct 26, 2026

Study contacts

Tiffany Phan, BA
Contact
tphan@chla.usc.edu
3234612142
Lindsay M Andras, MD
Contact
landras@chla.usc.edu
323-361-2148
Lindsay M Andras, MD
principal investigator · Children's Hospital Los Angeles

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion